BMS 276 Naden
Herceptin a. What is the validating target?
The HER protein receptor is what is targeted when treating breast
cancer with the drug.
What is the composition?
Carbon, Hydrogen, Nitrogen, Oxygen, and Sulfur are t
The benefit of the drug is the ability of the
medicine to bind to HER2 which binds to
HER receptor proteins thus inhibiting the
overall growth of the tumor.
It is also believed that it can trigger the
immune system to fight against the t
Used in adults experiencing anemia as a
result of chronic kidney disease.
Seeks to pose as a glycoprotein in order to
enhance red blood cell development.
In reality, it is a synthetic peptide that
attaches itself to polyethylene gly
BMS 276 Naden
Example of drug recalled
OMONTYS (peginesatide) was a drug that was injected for the use of treating
adults with anemia as a product of chronic kidney di
3. efficacy- what is the benefit of the drug? use GRAPH/TABLE form. these are the chart
you show the FDA before you get approval. conclusions/analysis from table/data
The general goal of Perjeta is to prevent the ability for HER2 cells to bind wi
3. Determination of Efficacy In vivo testing is used on live animals and humans alike,
while in vitro testing is done on isolated biological items in a lab. This is often refered to
as test tube experimentation. DNA, RNA and specific molecules